Henrique de Lima

Mr. Henrique de Lima

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Life Sciences
Verified
Journal Article
Closed access
Lorane Hage-MelimLorane Hage-Melim
Lorane Hage-Melim
LFLeonardo Bruno Federico
Leonardo Bruno Federico
NONayana Keyla Seabra de Oliveira
Nayana Keyla Seabra de Oliveira
VFViviane Cristina Cardoso Francisco
Viviane Cristina Cardoso Francisco
LCLenir Cabral Correia
Lenir Cabral Correia
CSCarlos Henrique Tomich de Paula da Silva
Carlos Henrique Tomich de Paula da Silva

26 August 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
RTRosana Tomazi
Rosana Tomazi
ÂFÂngela Costa Figueira
Ângela Costa Figueira
AFAdriana Maciel Ferreira
Adriana Maciel Ferreira
DFDiego Ferreira
Diego Ferreira
GSGisele Custódio de Souza
Gisele Custódio de Souza
Sheylla Susan De AlmeidaSheylla Susan De Almeida
Sheylla Susan De Almeida
Hancornia speciosa Gomes is a tree native to Brazil and has therapeutic potential for several diseases. Ethnopharmacological surveys have reported that the plant is used as a hypoglycemic agent and to lose weight. This study aimed to evaluate the effects of the aqueous extract from H. speciosa latex (LxHs) in a zebrafish model of diabetes. The extract was evaluated through high-performance thin-layer chromatography (HTPLC), nuclear magnetic resonance (NMR), and Fourier-transform infrared spectroscopy (FT-IR). We then tested treatments with LxHs (500, 1000, and 1500 mg/kg) by assessing blood glucose levels in alloxan-induced diabetic animals, and metformin was used as a control. The toxicity was evaluated through histopathology of the pancreas and biochemical assessment of serum levels of AST, ALT, creatinine, and urea. The extract was also assessed for acute toxicity through several parameters in embryos and adult animals. Finally, we performed in silico analysis through the SEA server and docking using the software GOLD. The phytochemical study showed the compounds cornoside, dihydrocornoide, and 1-O-methyl-myoinositol (bornesitol). The treatment with all doses of LxHs significantly decreased alloxan-induced hyperglycemia without any significant histological or biochemical abnormalities. No significant frequency of teratogenesis was observed in the embryos exposed to the extract, and no significant behavioral changes or deaths were observed in adult animals. In silico, the results showed a potential interaction between inositol and enzymes involved in carbohydrates’ metabolism. Overall, the results show a hypoglycemic activity of the extract in vivo, with no apparent toxicity. The computational studies suggest this could be at least partially due to the presence of bornesitol, since inositols can interact with carbohydrates’ enzymes.

13 October 2025 in Revista Brasileira de Farmacognosia
Verified
Journal Article
Closed access
PDF file
DMDaniela Miorando
Daniela Miorando
ASAmanda M. Steffler
Amanda M. Steffler
VSViviane L. Simomura
Viviane L. Simomura
CVCristian A. Dalla Vecchia
Cristian A. Dalla Vecchia
CFCleidiane V. Ferraz
Cleidiane V. Ferraz
Walter Antônio Roman JuniorWalter Antônio Roman Junior
Walter Antônio Roman Junior

1 January 2024 in Journal of the Brazilian Chemical Society
Verified
Journal Article
Closed access
HLHenrique de Lima
Henrique de Lima
GNGustavo Neves
Gustavo Neves
Itamar Luís GonçalvesItamar Luís Gonçalves
Itamar Luís Gonçalves
Aloir MerloAloir Merlo
Aloir Merlo
VEVera Lucia Eifler-Lima
Vera Lucia Eifler-Lima
In this review, the works carried out in Brazil with multicomponent reactions over a period of 30 years were mapped through search in the literature (PubMed, Scopus, and Web of Science). A significant increase in papers with multicomponent reactions in Brazil was identified. In total, 243 articles with 6,672 citations (average of 27.46 citations per article) were found. Biginelli, Ugi, Mannich, Passerini and Hantzsch are the most employed reactions, and the articles were classified in medicinal chemistry, catalyst, mechanism, green chemistry, asymmetric synthesis and fluorescent. A bibliometric analysis with the 243 articles was performed, including the number of publications, citations, predominant journals, Brazilian universities with the highest number of publications on the subject, and international collaborations.

24 September 2025 in Applied Sciences
Verified
Journal Article
Open access
PDF file
FSFranciane Nunes de Souza
Franciane Nunes de Souza
NONayana Oliveira
Nayana Oliveira
HLHenrique de Lima
Henrique de Lima
ASAbraão G. Silva
Abraão G. Silva
Rodrigo Alves Soares CruzRodrigo Alves Soares Cruz
Rodrigo Alves Soares Cruz
Lorane Hage-MelimLorane Hage-Melim
Lorane Hage-Melim
Background: The pathophysiology of Alzheimer’s disease (AD) is strongly linked to damage to the cholinergic systems of the central nervous system (CNS), mainly due to the formation of β-amyloid peptide plaques, which trigger intense inflammatory responses and are currently the main cause of the symptoms of the disease. Among the therapeutic strategies under investigation, classes of natural products with immunomodulatory properties, action on the CNS, and potent antioxidant activity, which contribute to neuroprotection, stand out. Methods: We aimed to evaluate the flavonoid quercetin using in silico, in vitro, and in vivo methods for the treatment of AD. Initially, the compounds were selected, and molecular dynamics simulations were performed. The in vitro assays included tests of antioxidant activity (DPPH), enzymatic inhibition of acetylcholinesterase (AChE), and prediction of oral toxicity. The in vivo studies investigated the effects on scopolamine-induced learning deficits and conducted histopathological analysis of the brain. Results: Quercetin showed structural stability in the complex with (AChE), with no significant alterations in the Root Mean Square Deviation (RMSD), SASA and radius of gyration (Rg) parameters. Through the same method it was possible to predict stability between the quercetin and inducible nitric oxide synthase (iNOS) complex, a possible mechanism for quercetin immunomodulation in the CNS. In the AChE inhibition test, the IC50 obtained for quercetin was 59.15 μg mL−1, while in the antioxidant test with DPPH, the concentration of 33.1 µM exhibited 50% of the scavenging of reactive oxygen species. This corroborates the perspective of quercetin having neuroprotective activity. This activity was also corroborated in vivo, in a zebrafish model, in which quercetin reduced the cognitive deficit induced by scopolamine. Histopathological analysis revealed its ability to prevent atrophy, caused by scopolamine, in the nervous tissue of animals, reinforcing the potential of quercetin as a neuroprotective agent. Conclusions: The results of the tests carried out with quercetin suggest that this molecule has antioxidant, AChE inhibitory, and neuroprotective activities, making it a good candidate for use in future clinical trials to ensure its efficacy and safety.

31 May 2022 in Toxicology Research
Verified
Journal Article
Closed access
SBSusy Barros
Susy Barros
HLHenrique de Lima
Henrique de Lima
LGLeandra Karoline Alves Gonçalves
Leandra Karoline Alves Gonçalves
LCLenir Cabral Correia
Lenir Cabral Correia
MBMaiara de Fátima de Brito Brito
Maiara de Fátima de Brito Brito
Lorane Hage-MelimLorane Hage-Melim
Lorane Hage-Melim
Kefiran is a polysaccharide present in kefir grains that have been widely explored due to its potential health benefits. The objective of this work was to characterize and quantify the components present in the ethanolic extract of milk kefir grains; to study its pharmacokinetic and toxicological properties in silico and evaluate the acute toxicity of the kefiran in zebrafish. The prediction of pharmacokinetic properties was performed by QikProp software. In silico toxicity assessment was performed using the DEREK (deductive estimate of risk from existing knowledge) software. In the chromatographic, kefiran was identified as the major component. Results showed that the kefiran had low human oral absorption and intestinal absorption its due poor solubility profile; low logP value, indicating its lipophilicity and the low MDCK and Caco-2 cells permability, and unable to cross the blood–brain barrier. Kefiran did not present any structural warning for in silico toxicity. In zebrafish, the dose of 2,000 mg/kg of kefiran produced nonsignificant alterations in the analyzed organs. It can be said then that kefiran has an acceptable degree of safety for use in the development of drugs or functional foods. Further research such as in vivo testing to confirm its pharmacological potential is currently underway.